FDA Seeks Public Input On Transparency

Main Category: Regulatory Affairs / Drug Approvals
Article Date: 24 Jun 2009 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The U.S. Food and Drug Administration will host a daylong meeting on June 24, 2009. During this meeting, the FDA will seek recommendations on how to make information on FDA activities and decision-making useful, understandable, and more accessible to the public. The meeting is scheduled for 8 a.m. to 5 p.m. EDT at the National Transportation Safety Board Conference Center, 429 L'Enfant Plaza, S.W., Washington, D.C., 20594.

Please note there is no wireless service within the NTSB Conference Center. If you have questions, please e-mail them to Transparency.Meeting@fda.hhs.gov.

Those who cannot attend the meeting can view the event via live Webcast at: http://www.fda.gov/transwebcast_june09. After the meeting, the Webcast will be available for viewing at the same link.

For more information:

June 3, 2009 Federal Register Notice
FDA's Transparency Task Force
FDA's Transparency Blog

Source
U.S. Food and Drug Administration

Article adapted by Medical News Today from original press release.
Visit our regulatory affairs / drug approvals section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
U.S. Food and Drug Administration. "FDA Seeks Public Input On Transparency." Medical News Today. MediLexicon, Intl., 24 Jun. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/155194.php>

APA
U.S. Food and Drug Administration. (2009, June 24). "FDA Seeks Public Input On Transparency." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/155194.php.

Please note: If no author information is provided, the source is cited instead.


Regulatory Affairs / Drug Approvals

Most Popular Articles



Follow Our Regulatory Affairs News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Regulatory Affairs / Drug Approvals Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »